ARxIUM’s RIVA Rated Highest Performing IV Robot in Pharmacy Study

Independent healthcare research firm KLAS reported RIVA leads in improving productivity and minimizing medication spending.

RIVA, the fully automated IV compounding system developed by ARxIUM, has been recognized as the highest performing IV robot by independent healthcare research firm KLAS. The rating was announced in its "Pharmacy 2016: Are You Partnered to Reduce Costs?" report, which surveyed hospital executives and pharmacy directors about value-based care initiatives and other topics.


RIVA's overall performance score of 85.9 was the highest for IV robots evaluated and scored more than 20 percent higher than its closest competitor. KLAS also reported that RIVA leads in accuracy and patient safety, and customers feel it is more reliable than the competition. In addition, RIVA was rated the top IV robot for improving staff productivity and minimizing medication spending.

"As decreasing reimbursements and global healthcare reform initiatives reshape capital expenditures, hospital administrators are looking for ways to reduce pharmacy costs," said Dr. Niels Erik Hansen, president and CEO of ARxIUM. "The latest KLAS report proves RIVA is meeting that need, while also increasing accuracy, patient safety and efficiency. Additionally, continued pharmacy recalls, heightened regulations and expensive medication outsourcing demonstrate the need for RIVA's unmatched technology."

RIVA is engineered with multiple safety technologies and prepares IV medications in an aseptic ISO Class 5 environment with laminar airflow. RIVA units have been installed worldwide and have cumulatively produced millions of IV doses safely and accurately. RIVA was recognized by KLAS as the Category Leader in "Pharmacy Automation: IV Robots" in its "2015 Best in KLAS: Medical Equipment & Infrastructure" report.

KLAS report citations:
"Pharmacy 2016: Are You Partnered To Reduce Costs," March 2016. © 2016 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com.
"2015 Best in KLAS: Medical Equipment & Infrastructure," November 2015. © 2015 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com.

About ARxIUM
Based in Winnipeg, Manitoba and Buffalo Grove, Illinois, ARxIUM delivers best-in-class technology and unparalleled expertise to help pharmacies of all sizes improve safety, productivity and efficiency. The company provides scalable, comprehensive solutions for every segment of the pharmacy market. ARxIUM's offering includes automated compounding, packaging and dispensing, compliance packaging management, inventory control and storage, workflow and scheduling software, production and workflow design, and technical consulting and implementation assistance, among other services. The company is the first to offer a Total Dose Solution, a customizable, end-to-end solution for oral-solid and IV dose preparation. For more information, visit www.arxium.com.

Featured Product

BitFlow Introduces 6th Generation Camera Link Frame Grabber: The Axion

BitFlow Introduces 6th Generation Camera Link Frame Grabber: The Axion

BitFlow has offered a Camera Link frame grabbers for almost 15 years. This latest offering, our 6th generation combines the power of CoaXPress with the requirements of Camera Link 2.0. Enabling a single or two camera system to operate at up to 850 MB/S per camera, the Axion-CL family is the best choice for CL frame grabber. Like the Cyton-CXP frame grabber, the Axion-CL leverages features such as the new StreamSync system, a highly optimized DMA engine, and expanded I/O capabilities that provide unprecedented flexibility in routing. There are two options available; Axion 1xE & Axion 2xE. The Axion 1xE is compatible with one base, medium, full or 80-bit camera offering PoCL, Power over Camera Link, on both connectors. The Axion 2xE is compatible with two base, medium, full or 80-bit cameras offering PoCL on both connectors for both cameras. The Axion-CL is a culmination of the continuous improvements and updates BitFlow has made to Camera Link frame grabbers.